PULMATRIX, INC. Current Liabilities
PULMATRIX, INC. (PULM) had Current Liabilities of $689.00 thousand as of 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-09-17
- 2026-06-30: Liabilities, Current $689.00K.
- 2026-03-31: Liabilities, Current $905.00K.
- 2025-12-31: Liabilities, Current $329.00K.
- 2025-09-30: Liabilities, Current $249.00K.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $689.00K S-4/A · filed 2026-09-17 | |
| 2026-03-31 | $905.00K S-4/A · filed 2026-08-03 | |
| 2025-12-31 | $329.00K S-4/A · filed 2026-09-17 | |
| 2025-09-30 | $249.00K 10-Q · filed 2025-10-16 | |
| 2025-06-30 | $548.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $903.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $929.00K S-4/A · filed 2026-09-17 | |
| 2024-09-30 | $590.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $2.47M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.14M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $3.91M 10-K · filed 2025-03-21 | |
| 2023-09-30 | $4.43M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.60M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.73M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $5.02M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $6.32M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.60M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $5.38M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $4.44M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $5.13M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $6.92M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $7.09M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $8.18M 10-K · filed 2022-03-29 | $8.25M 10-K · filed 2021-03-23 |
| 2020-09-30 | $10.57M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $14.64M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $17.36M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $17.20M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $11.73M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $12.75M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $3.79M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.88M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $3.65M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $3.78M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $6.20M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $5.84M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $6.51M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $5.89M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $4.33M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $4.65M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $4.11M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $4.11M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $4.01M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $3.60M 10-K · filed 2017-03-10 | |
| 2015-09-30 | $2.48M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.33M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $635.00K 10-K · filed 2015-06-10 | |
| 2014-12-31 | $43.46M 10-K · filed 2016-03-10 | $575.00K 10-Q · filed 2015-02-13 |
| 2014-09-30 | $575.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $550.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $947.00K 10-K · filed 2015-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |